NanoHive Medical Expands 3D Printed Titanium Device Portfolio

NanoHive Medical LLC has received U.S. Food and Drug Administration 510(k) clearance for its 22mm length Hive PL Interbody System. The 22 millimeter length implants are a line extension to the current Hive PLIF interbody devices and feature a 9 millimeter width and various height and lordotic options to accommodate patient anatomy.
 
Additionally, the regulatory clearance includes updated description of the microscopic roughened surfaces with micro and nano-scale features found on all surfaces of the Hive Soft Titanium interbodies, including the superior, inferior, and peripheral surfaces, as well as each member of the internal cell structure.
 
The company’s Hive Lumbar Interbody System, with a microscopic roughened surface and micro and nano-scale features, is designed to treat degenerative disc disease (DDD) at one or two contiguous levels from L2-S1. The system must be used with supplemental fixation, with autograft or allograft bone.
 
NanoHive Medical develops 3D printed spinal interbody fusion implants and instrumentation. The company’s proprietary, biomimetic Soft Titanium technology distinguishes their products in the $1.9 billion spinal interbody fusion device market. The Hive portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration—features that lead to consistently strong fusion constructs and efficacious clinical experiences.
 
NanoHive Medical is located in Woburn, Mass.